Education Use Only
For educational use only — Not for clinical decision-making without independent verification
Medical Associates  ·  Department of Nephrology ← urinenephrology.org
Nephrology Education Series

Hyponatremia: Student Handout

Andrew Bland, MD, FACP, FAAP UICOMP · UDPA · Butler COM 2026-02-12 9 min read

Hyponatremia: A Student Guide to Low Sodium

Learning Objectives

By completing this handout, you should be able to: - Define hyponatremia and recognize its clinical significance - Explain the physiologic mechanisms that maintain water and sodium balance - Systematically approach a patient with hyponatremia - Calculate and interpret the Furst ratio for fluid restriction response - Implement evidence-based treatment strategies

Quick Definition

Hyponatremia = Serum sodium <135 mEq/L (normal: 135-145 mEq/L)

Think of it as too much water relative to sodium, not simply too little sodium.

Severity and Symptoms

Severity Na+ Level Symptoms Timeline
Mild 130-134 Fatigue, difficulty concentrating Often asymptomatic
Moderate 125-129 Headache, nausea, confusion Hours to days
Severe <125 Seizures, coma, respiratory arrest Immediate concern

Critical Point: Acute hyponatremia (developing in <48 hours) causes more severe symptoms at milder sodium levels compared to chronic hyponatremia. A patient with Na+ 128 developed acutely may seize, while another patient with Na+ 115 chronically may only have mild symptoms.

The Two Hormone Systems

1. Antidiuretic Hormone (ADH) System

  • Regulates: Water balance
  • Monitored by: Blood osmolality (280-290 mOsm/kg)
  • Response: High ADH → water retention → concentrated urine
  • Key test: Urine osmolality

2. Aldosterone System (RAAS)

  • Regulates: Sodium balance
  • Monitored by: Effective arterial blood volume
  • Response: High aldosterone → sodium and water retention
  • Key test: Urine sodium + Clinical volume assessment

Think of it this way: One thermostat controls temperature (ADH=water), another controls humidity (aldosterone=sodium). They work independently!

Clinical Assessment: The Four Questions

1. How severe is it?

  • Serum sodium level
  • Symptom presence (especially neurologic)
  • Rate of development (acute vs. chronic)

2. What is the volume status?

Hypovolemic (total body sodium ↓, water ↓↓) - Signs: Orthostatic hypotension, tachycardia, dry mucous membranes, flat neck veins - Causes: Vomiting, diarrhea, diuretics, third-spacing

Euvolemic (total body sodium normal, water ↑) - Signs: Normal BP, normal physical exam, no edema - Causes: SIADH, hypothyroidism, adrenal insufficiency

Hypervolemic (total body sodium ↑, water ↑↑) - Signs: Edema, elevated JVP, pulmonary edema - Causes: Heart failure, cirrhosis, nephrotic syndrome, renal failure

3. What is the urine osmolality?

This is the most important test - tells you about ADH activity.

  • <100 mOsm/kg: ADH suppressed (primary polydipsia, beer potomania)
  • 100-300 mOsm/kg: Partial effect or mixed picture
  • >300 mOsm/kg: Significant ADH effect (SIADH, hypovolemic states)
  • >500 mOsm/kg: Strong ADH effect (classic for SIADH)

4. What medications is the patient taking?

Common culprits: - SSRIs/SNRIs (paroxetine, venlafaxine) → SIADH pattern - Thiazide diuretics (HCTZ) → mixed picture initially - Carbamazepine, oxcarbazepine → SIADH - NSAIDs, ACE inhibitors → impaired water excretion

The Diagnostic Algorithm

HYPONATREMIA (Na+ <135)
    ↓
Assess volume status (physical exam)
    ↓
├─ HYPOVOLEMIC → Causes: GI losses, diuretics, adrenal insufficiency
│  └─ Urine Na+ usually <20 mEq/L (appropriate kidney retention)
│
├─ EUVOLEMIC → Causes: SIADH, hypothyroidism, polydipsia
│  └─ Urine osmolality >300 suggests SIADH
│
└─ HYPERVOLEMIC → Causes: Heart failure, cirrhosis, renal disease
   └─ Urine Na+ >20 mEq/L (kidney can't conserve despite volume overload)

The Furst Ratio: Predicting Fluid Restriction Response

Formula: Furst Ratio = (Urine Na+ + Urine K+) / Serum Na+

Interpretation: - <0.5: Likely to respond to fluid restriction - 0.5-1.0: May respond to severe restriction (<500 mL/day) - >1.0: Unlikely to respond; consider alternative therapy

Clinical Significance: Up to 60% of SIADH patients have unfavorable Furst ratios, meaning fluid restriction alone won’t work effectively. These patients need urea therapy, SGLT2 inhibitors, or vaptans.

Important: Fluid restriction has LIMITED EVIDENCE and poor adherence rates (<50%). If Furst ratio unfavorable, don’t waste time on fluid restriction—move to proven therapies.

Treatment by Severity and Cause

Severe Symptomatic Hyponatremia (Seizures/Coma)

  • Goal: Raise Na+ by 4-6 mEq/L to stop symptoms
  • Treatment: 3% hypertonic saline
    • Bolus: 150 mL over 10-20 minutes, repeat 2-3 times
    • Check Na+ after each bolus
  • Key concept: Correct just enough to stop symptoms, then slow down

Symptomatic Without Severe Neurologic Symptoms

  • Goal: Gradual correction, 6-10 mEq/L per 24 hours
  • Treatment: Based on cause
    • Hypovolemic → isotonic saline (0.9%)
    • Euvolemic → fluid restriction initially; if fails → urea or SGLT2i
    • Hypervolemic → address underlying condition (diuretics, etc.)

Asymptomatic Hyponatremia

  • Goal: Gradual correction, 6-8 mEq/L per 24 hours
  • Treatment: Address underlying cause
  • Caution: Slow correction minimizes osmotic demyelination syndrome risk

The Saline Paradox (Critical Concept!)

Normal saline can WORSEN hyponatremia in SIADH!

Why? - Normal saline has osmolality ~308 mOsm/kg - If urine osmolality >308 mOsm/kg, kidneys excrete saline’s sodium in smaller water volume - Result: Patient retains free water → Na+ drops further

Solution: Check urine osmolality before giving IV fluids - If >350 mOsm/kg → use hypertonic (3%) saline - If <300 mOsm/kg → normal saline is safe

Emerging Therapies

Urea (15-60g daily)

  • Osmotic agent promoting free water excretion
  • Safe, predictable, inexpensive
  • Now preferred second-line therapy
  • Mix with juice to improve taste

SGLT2 Inhibitors (e.g., empagliflozin 10mg daily)

  • Induce glucosuria → osmotic diuresis
  • Dual benefit in heart failure patients
  • Takes days to work
  • Contraindicated in severe renal impairment

Overcorrection Prevention

Osmotic Demyelination Syndrome (ODS) risk when: - Correction >8-10 mEq/L per 24 hours - Severe hyponatremia (<115 mEq/L) - Chronic alcoholism, malnutrition, liver disease

Management if overcorrection occurs: 1. Stop sodium-containing infusions immediately 2. Give desmopressin (dDAVP) 2-4 μg IV/SC 3. Start D5W infusion 4. Monitor Na+ every 1-2 hours 5. Goal: Re-lower sodium to safer range

Clinical Pearls

  1. Urine osmolality is king - This single test provides most diagnostic information
  2. Always check volume status first - Determines initial treatment approach
  3. Medications matter - SSRIs, thiazides are common culprits
  4. Correct slowly, especially if chronic - Risk of ODS outweighs benefits of rapid correction
  5. Address the cause - Treating hyponatremia without fixing underlying problem leads to relapse
  6. Concurrent hypomagnesemia prevents potassium correction - Always check and replace Mg2+

Practice Questions

Question 1: A 72-year-old woman on hydrochlorothiazide presents with Na+ 128 mEq/L, urine osmolality 45 mOsm/kg, and orthostatic hypotension. What’s the likely diagnosis?
Answer Thiazide-induced hyponatremia with hypovolemia. The low urine osmolality indicates appropriate ADH suppression (kidneys trying to retain water). The orthostasis confirms volume depletion. Treatment: discontinue diuretic and give isotonic saline carefully (risk of overcorrection once volume is restored).
Question 2: A 55-year-old man with SIADH from lung cancer has Na+ 128 mEq/L and urine osmolality 580 mOsm/kg. Furst ratio is 1.2. He’s miserable from thirst despite 800mL fluid restriction. What would you do?
Answer Don’t continue torturing him with fluid restriction! Furst >1.0 predicts failure. Start urea 30g daily or SGLT2 inhibitor. These have proven efficacy and allow more liberal fluid intake, improving quality of life while safely correcting sodium.
Question 3: A 45-year-old with acute symptomatic hyponatremia (Na+ 115, seizures) receives 150mL 3% saline. Na+ rises to 120. What’s your next step?
Answer STOP aggressive correction. The seizure risk is gone at Na+ 120. Continue careful correction (target 6-8 mEq/L per 24 hours). Consider dDAVP clamp if high ODS risk. Seizing patients need urgent treatment, but once symptoms resolve, switch to conservative approach.

Key Takeaways for Exams

  • Hyponatremia = water excess (or sodium deficit)
  • Always assess volume status first
  • Urine osmolality distinguishes SIADH from hypovolemic hyponatremia
  • Furst ratio >1.0 means fluid restriction will fail
  • Urea and SGLT2i are now preferred second-line therapies
  • Correct slowly, especially in chronic hyponatremia
  • Urine osmolality >350 → use hypertonic saline (normal saline paradox)
  • Overcorrection causes osmotic demyelination → prevent with desmopressin if needed

References

  • Hyponatremia-treatment standard 2024. Nephrology Dialysis Transplantation
  • Winzeler B, et al. Predictors of nonresponse to fluid restriction in SIADH. J Clin Endocrinol Metab. 2019
  • Current review synthesizes 2024-2025 evidence on emerging therapies

Study Tip: Draw a simple diagram with “total body Na+” on one axis and “total body water” on the other. Hypovolemic hyponatremia is down-left. Euvolemic is right. Hypervolemic is up-right. This helps organize the clinical approach.

See Also

Clinical Content (01-Clinical-Medicine/Nephrology)

  • Electrolyte Disorders Hub
  • Sodium Disorders Clinical Reference
  • Essential Renal Laboratory Tests

Atomic Notes (ZK)

  • Hyponatremia Classification and Pathophysiology
  • Medication-Induced Hyponatremia
  • Overcorrection Prevention in Hyponatremia
  • Specialized Hyponatremia Treatment

Butler-COM Resources

  • Butler COM - Nephrology Deep Dive

References

  • Hyponatremia-treatment standard 2024. Nephrology Dialysis Transplantation
  • Winzeler B, et al. Predictors of nonresponse to fluid restriction in SIADH. J Clin Endocrinol Metab. 2019
  • Current review synthesizes 2024-2025 evidence on emerging therapies

Clinical Resources

  • Clinical Review: Hyponatremia Paper — Comprehensive clinical review with PubMed references
  • Clinical Review: Literature Review Correction Speed Of Hyponatremia And Associated Risks Of Mortality And Osmotic Demyelination Syndrome — Comprehensive clinical review with PubMed references
  • Clinical Review: Hyponatremia Complete Student Guide — Comprehensive clinical review with PubMed references
  • Clinical Review: Mercy Nursing Hyponatremia — Comprehensive clinical review with PubMed references
  • Clinical Review: Hyponatremia Comprehensive Hyponatremia Guide May 22 2025 — Comprehensive clinical review with PubMed references
  • Clinical Review: Hyponatremia Furst Ratio Comprehensive Evidence Based Expansion — Comprehensive clinical review with PubMed references
  • Clinical Review: Ich Hyponatremia Report — Comprehensive clinical review with PubMed references